Filing Details
- Accession Number:
- 0001179110-22-001397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-17 18:11:48
- Reporting Period:
- 2022-02-15
- Accepted Time:
- 2022-02-17 18:11:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 11 | $296.18 | 138,379 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 32 | $298.50 | 138,347 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 157 | $301.00 | 138,190 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 159 | $301.56 | 138,031 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 312 | $302.70 | 137,719 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 460 | $303.65 | 137,259 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 536 | $304.52 | 136,723 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 185 | $305.71 | 136,538 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-02-15 | 148 | $306.68 | 136,390 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the sale price of the transactions on the reported date at $296.18. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $298.50. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $301.0046. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $301.5608. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $302.6986. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $303.6477. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $304.5160. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $305.7072. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $306.6811. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
